THE DESIGN AND BIOACTIVATION OF PRESYSTEMICALLY STABLE PRODRUGS

[1] Aldridge WN, 1972, FRONTIERS BIOL, V26

[2] NADPH CYTOCHROME-P-450 REDUCTASE ACTIVATION OF QUINONE ANTI-CANCER AGENTS TO FREE-RADICALS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (02) : 954 - 957

[3] IS FORMATION OF REACTIVE OXYGEN BY CYTOCHROME-P-450 PERILOUS AND PREDICTABLE [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1986, 7 (07) : 266 - 270

[4] BODOR N, 1985, DESIGN PRODRUGS, P333

[5] HUMAN CYTOCHROMES-P-450 [J]. XENOBIOTICA, 1984, 14 (1-2) : 151 - 185

[6] MOLECULAR-FORMS OF ACETYLCHOLINESTERASE IN BRAIN, NERVE AND MUSCLE - NATURE, LOCALIZATION AND DYNAMICS [J]. PROGRESS IN NEUROBIOLOGY, 1983, 21 (04) : 291 - 322

[7] THE PLASMA CHOLINESTERASES - A NEW PERSPECTIVE [J]. ADVANCES IN CLINICAL CHEMISTRY, 1981, 22 : 1 - 123

[8] BEHAVIORAL-EFFECTS OF (-)10,11-METHYLENEDIOXY-N-NORMAL-PROPYLNORAPORPHINE, AN ORALLY EFFECTIVE LONG-ACTING AGENT ACTIVE AT CENTRAL DOPAMINE-RECEPTORS, AND ANALOGOUS APORPHINES [J]. NEUROPHARMACOLOGY, 1982, 21 (10) : 953 - 961

[9] CARBOXYLESTERASES IN PRIMATE BRAIN - CHARACTERIZATION OF MULTIPLE FORMS [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1983, 15 (08): : 1019 - 1025

[10] CRESPI F, 1979, EUR J DRUG METAB PH, V3, P175

[1] Aldridge WN, 1972, FRONTIERS BIOL, V26

[2] NADPH CYTOCHROME-P-450 REDUCTASE ACTIVATION OF QUINONE ANTI-CANCER AGENTS TO FREE-RADICALS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (02) : 954 - 957

[3] IS FORMATION OF REACTIVE OXYGEN BY CYTOCHROME-P-450 PERILOUS AND PREDICTABLE [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1986, 7 (07) : 266 - 270

[4] BODOR N, 1985, DESIGN PRODRUGS, P333

[5] HUMAN CYTOCHROMES-P-450 [J]. XENOBIOTICA, 1984, 14 (1-2) : 151 - 185

[6] MOLECULAR-FORMS OF ACETYLCHOLINESTERASE IN BRAIN, NERVE AND MUSCLE - NATURE, LOCALIZATION AND DYNAMICS [J]. PROGRESS IN NEUROBIOLOGY, 1983, 21 (04) : 291 - 322

[7] THE PLASMA CHOLINESTERASES - A NEW PERSPECTIVE [J]. ADVANCES IN CLINICAL CHEMISTRY, 1981, 22 : 1 - 123

[8] BEHAVIORAL-EFFECTS OF (-)10,11-METHYLENEDIOXY-N-NORMAL-PROPYLNORAPORPHINE, AN ORALLY EFFECTIVE LONG-ACTING AGENT ACTIVE AT CENTRAL DOPAMINE-RECEPTORS, AND ANALOGOUS APORPHINES [J]. NEUROPHARMACOLOGY, 1982, 21 (10) : 953 - 961

[9] CARBOXYLESTERASES IN PRIMATE BRAIN - CHARACTERIZATION OF MULTIPLE FORMS [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1983, 15 (08): : 1019 - 1025

[10] CRESPI F, 1979, EUR J DRUG METAB PH, V3, P175